Blog

Annals of Oncology – Long-term results of the UNICANCER-PRODIGE 23 trial

Photo taken from yourgenome.org

Jul 11, 2024, 04:05

Annals of Oncology – Long-term results of the UNICANCER-PRODIGE 23 trial

Annals of Oncology shared on X:

“New article in press: Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Authors: T. Conroy, F. Castan, P.-L. Etienne, E. Rio, N. Mesgouez-Nebout, L. Evesque, V. Vendrely, X. Artignan, O. Bouché, D. Gargot, V. Boige, MD, N. Bonichon-Lamichhane, C. Louvet, C. Morand, C. de la Fouchardière, A. Boilève, M. Delaye, S. Gourgou, V. Pezzella, C. Borg.”

Annals of Oncology

Source: Annals of Oncology/X

A. Boilève Annals of Oncology C. Borg C. de la Fouchardière C. Louvet C. Morand cancer D. Gargot E. Rio F. Castan L. Evesque M. Delaye MD N. Bonichon-Lamichhane N. Mesgouez-Nebout O. Bouché OncoDaily Oncology P.-L. Etienne S. Gourgou T. Conroy V. Boige V. Pezzella V. Vendrely X. Artignan

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage